Radial or Focus Extracorporeal Shock Wave Therapy in Epin Calcanei

Investigation of The Effectiveness of Extracorporeal Shock Wave Therapy in Patients Diagnosed With Epin Calcanei: Comparison of Radial and Focus Applications

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06356064

Enrollment

112

Registered

2024-04-10

Start date

2023-05-15

Completion date

2024-01-15

Last updated

2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spur, Heel

Brief summary

Objective: The aim of the study was to investigate the effectiveness of radial and focused ESWT treatment on pain, function, and size of the calcaneal spur in patients with a clinical and radiological diagnosis of epin calcanei. Methods: A total of 112 patients aged between 18 and 95 years were randomly divided into two groups: group 1 received rESWT (2.4 bar 12 hz 2000 beats), and group 2 received fESWT (0.14 bar 14 hz 1000 beats) three times a week for three weeks. All patients were evaluated using the Visual Analog Scale (VAS)-pain and Foot Function Index (FFI) before and after the treatment, at 4 weeks and 12 weeks. Epin size was measured radiographically in the patients before and after the treatment at the 12-week follow-up.

Interventions

DEVICEExtracorporeal shock wave therapy

Radİal ESWT and focus ESWT

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

18 Years to 95 Years

Healthy volunteers

Inclusion criteria

; * Presence of heel pain for at least four weeks, * Receiving no medical treatment, injection, physical or surgical treatment for the last four weeks and * Agreed to participate in the study.

Exclusion criteria

* History of fracture or surgery, * Polyneuropathy, * Rheumatological diseases, * Coagulation disorders, * Tumor, * Thrombosis, * Soft tissue or bone infection, * Pregnancy and lactation, * Epilepsy, * Presence of a pacemaker.

Design outcomes

Primary

Measure	Time frame	Description
Visual Analog Scale	Before and after treatment baseline, 4th week, 12 th week	0 min , 10 is maximum pain score
Functional Foot Index	Before and after treatment baseline, 4th week, 12 th week	0 is no pain 10 is max pain, and 0 is no deficiency 10 is the maximum deficiency and 0 is no activity limitation 10 is the maximum activity limitation score.

Secondary

Measure	Time frame	Description
Radiographic assesment, epin size	Before and after treatment baseline, 4th week, 12 th week	A decrease in the size of the epin is an indicator of recovery.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026